Effect of Lactocare® Synbiotic on Disease Severity in Ulcerative Colitis: A Randomized Placebo-Controlled Double-Blind Clinical Trial

BACKGROUND Inflammatory bowel diseases are managed by different methods, which may not be well tolerated because of their side effects. Recently, pro-prebiotics are considered as a supplementary treatment in gastrointestinal diseases. In this study, the effect of Lactocare® (ZistTakhmir Company) was...

Descripción completa

Detalles Bibliográficos
Autores principales: Amiriani, Taghi, Rajabli, Niloofar, Faghani, Maryam, Besharat, Sima, Roshandel, Gholamreza, Akhavan Tabib, Atefeh, Joshaghani, Hamidreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Association of Gastroerterology and Hepatology 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023645/
https://www.ncbi.nlm.nih.gov/pubmed/32082518
http://dx.doi.org/10.15171/mejdd.2020.160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023645/
https://www.ncbi.nlm.nih.gov/pubmed/32082518
http://dx.doi.org/10.15171/mejdd.2020.160

Ejemplares similares